| <p>Speciality Medicines Limited will hold a meeting of its Board of Directors on November 12, 2026, to consider and approve the unaudited standalone financial results for the half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The trading window for the company's insiders, including directors, promoters, designated persons, senior management personnel, and their immediate relatives, was closed on October 1, 2026, and will reopen 48 hours after the board meeting concludes.</p> |